MedApp Statistics

Total Valuation

MedApp has a market cap or net worth of PLN 56.28 million. The enterprise value is 60.86 million.

Market Cap	56.28M
Enterprise Value	60.86M

Important Dates

The last earnings date was Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

MedApp has 250.13 million shares outstanding.

Current Share Class	250.13M
Shares Outstanding	250.13M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	120.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.57
PB Ratio	2.09
P/TBV Ratio	3.76
P/FCF Ratio	36.69
P/OCF Ratio	11.01
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.08, with an EV/FCF ratio of 39.67.

EV / Earnings	-654.41
EV / Sales	13.59
EV / EBITDA	27.08
EV / EBIT	164.04
EV / FCF	39.67

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.07.

Current Ratio	1.00
Quick Ratio	0.25
Debt / Equity	0.07
Debt / EBITDA	0.86
Debt / FCF	1.26
Interest Coverage	2.36

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	0.03%
Return on Capital Employed (ROCE)	1.33%
Weighted Average Cost of Capital (WACC)	7.21%
Revenue Per Employee	559,750
Profits Per Employee	-11,625
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MedApp has paid 213,000 in taxes.

Income Tax	213,000
Effective Tax Rate	97.71%

Stock Price Statistics

The stock price has increased by +25.13% in the last 52 weeks. The beta is 0.58, so MedApp's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+25.13%
50-Day Moving Average	0.15
200-Day Moving Average	0.16
Relative Strength Index (RSI)	50.22
Average Volume (20 Days)	336,196

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedApp had revenue of PLN 4.48 million and -93,000 in losses. Loss per share was -0.00.

Revenue	4.48M
Gross Profit	2.89M
Operating Income	371,000
Pretax Income	218,000
Net Income	-93,000
EBITDA	2.25M
EBIT	371,000
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 228,000 in cash and 1.93 million in debt, giving a net cash position of -1.70 million or -0.01 per share.

Cash & Cash Equivalents	228,000
Total Debt	1.93M
Net Cash	-1.70M
Net Cash Per Share	-0.01
Equity (Book Value)	26.89M
Book Value Per Share	0.10
Working Capital	53,000

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.11 million and capital expenditures -3.58 million, giving a free cash flow of 1.53 million.

Operating Cash Flow	5.11M
Capital Expenditures	-3.58M
Free Cash Flow	1.53M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 64.43%, with operating and profit margins of 8.28% and -2.08%.

Gross Margin	64.43%
Operating Margin	8.28%
Pretax Margin	4.87%
Profit Margin	-2.08%
EBITDA Margin	50.18%
EBIT Margin	8.28%
FCF Margin	34.26%

Dividends & Yields

MedApp does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.17%
FCF Yield	2.73%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedApp has an Altman Z-Score of 2.22 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	2